Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).

MLA

Degim, Z., et al. “Investigation of Liposome Formulation Effects on Rivastigmine Transport through Human Colonic Adenocarcinoma Cell Line (CACO-2).” Die Pharmazie, vol. 65, no. 1, Jan. 2010, pp. 32–40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20187576&authtype=sso&custid=ns315887.

APA

Degim, Z., Mutlu, N. B., Yilmaz, S., Eşsiz, D., & Nacar, A. (2010). Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2). Die Pharmazie, 65(1), 32–40.

Chicago

Degim, Z, N B Mutlu, S Yilmaz, D Eşsiz, and A Nacar. 2010. “Investigation of Liposome Formulation Effects on Rivastigmine Transport through Human Colonic Adenocarcinoma Cell Line (CACO-2).” Die Pharmazie 65 (1): 32–40. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20187576&authtype=sso&custid=ns315887.